📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

New drugs under development for COPD. (2022)

First Author: Uwagboe I

Attributed to: 'COVAIR': Is SARS-CoV-2 airborne and does it interact with particle pollutants? funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.23736/s0026-4806.22.08024-7

PubMed Identifier: 35142480

Publication URI: http://europepmc.org/abstract/MED/35142480

Type: Journal Article/Review

Volume: 113

Parent Publication: Minerva medica

Issue: 3

ISSN: 0026-4806